Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 07, 2019

SELL
$33.73 - $46.27 $283,433 - $388,806
-8,403 Closed
0 $0
Q2 2019

Jul 25, 2019

BUY
$29.6 - $40.93 $248,728 - $343,934
8,403 New
8,403 $344,000
Q1 2019

Apr 15, 2019

SELL
$27.85 - $38.09 $279,502 - $382,271
-10,036 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$32.39 - $42.05 $325,066 - $422,013
10,036 New
10,036 $363,000

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.28B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.